• Trial Talks Podcast
  • COVID-19
  • Blog
  • Client Login

Meet Medrio Recap: Get Your Devices to Market Faster


A question we hear a lot from our medical device and MedTech customers is, how can I get my devices to market faster?

Based on what we’ve heard and seen from clients, we’ve managed to distill the answer into five success factors. All factors are based on technology and when we’ve seen them implemented with our clients we’ve seen profound innovations.

With these five success factors you will see innovation, faster time to market, and drive down your timelines.

1. Reduce or Remove Paper

A 2020 survey on the State of Medical Device Product Development and Quality Management found that more than 50% of medical device companies still use paper.

When it comes to paper, many think that it’s cheaper, quicker, and easier than eClinical solutions. This could be true for an initial pilot study with a handful of patients, but once device studies start to scale, and they scale quickly, paper starts to come with a lot of hidden costs. A cost comparison between the two often finds electronic solutions cheaper than paper.

Many medical device companies don’t want to make the switch to electronic solutions to avoid complying with the FDA’s 21 CFR Part 11. The reality is that if you send documents via email, have servers that store electronic documents, or sign paper documents then upload them, you’re already in the realm of electronic records.

Sponsors who have digitized their studies noted four key advantages:

  • Cost reduction by 50% per participant vs traditional onsite study methods
  • Increase trial recruitment and diversity
  • Higher participant compliance, more data collected
  • Data quality goes up; Data entry errors eliminated; Complete study on time from anywhere

Though there may be initial challenges when switching to electronic solutions, what you gain in the long run is worth it.

2. Use ‘Right-Sized’ Technology

The process of implementing ‘right-sized’ technology requires a technology partner who genuinely cares about your study’s success. Medrio works hand-in-hand with our customers, tailoring our technologies and services to meet your study’s precise needs, speed, and specifications.

‘Right-sized’ technology is easy to understand and adopt. Medrio solutions are built with the end user in mind, and our intuitive, drag-and-drop platform supports our guided autonomy approach, allowing us to provide a unique balance of support and autonomy to each customer. We’ve worked with organizations that have used our training and onboarding services to enable totally independent study builds from scratch. We’ve also worked with customers who prefer to sit back and let us complete the study build while they focus on other priorities. Our guided autonomy approach ensures we provide the technology and support that’s the exact right size for your study.

‘Right-sized’ technology does not require specialized staff. Our technology platform is programerless, meaning no specialized programming or coding capabilities are required. Additionally, our solutions have pre-built integrated workflows so all of our solutions- including platforms such as EDC, eConsent, and ePRO – interact with one another seamlessly. As a result, internal IT teams are less burdened, and third-party spending is reduced.

When looking for ‘right-sized’ technology, make sure you really need every bell and whistle. And if you don’t, consider asking yourself if you’ve found the right technology partner. Most importantly, you’ll want transparent pricing and predictable costs, so you’re not paying for things you don’t need.

3. Reuse Technology

Unlike pharma studies, the development process for medical device trials benefits greatly from iteration. In other words, there’s an opportunity to save time and money by reusing or repurposing existing workflows, forms, queries and functionality. By taking advantage of the ability to reuse, for example, previously built diaries or ePRO questionnaires, your team can dramatically improve subsequent study build and start times, while also reducing costs. Essentially, reusing technology saves your team from having to duplicate work which directly impacts getting your device to market faster.

4. Apply Integrated Solutions

In 2020, the Tufts Center for the Study of Drug Development found that a majority of sponsors were using at least four different solutions or platforms in their studies to obtain basic trial data. Building your eClinical technology stack this way increases costs, complexity, study delays, and inevitably frustration.

In contrast, Medrio’s solutions provide a much more streamlined experience. We provide a single user interface with a consistent look and feel across solutions, so you don’t have to learn more than one. Also, our solutions are fully integrated, so you don’t have to use expensive APIs to transmit data. Your patients can receive notifications and view instructions for at-home collection or procedures via our participant portal. And to round out our solution suite, we offer an integrated CTMS and eTMF through one of our technology partners.

When making the switch to electronic solutions, prioritize ones that are already integrated to save yourself from headaches and having to learn how to use multiple systems.

5. Prepare for Mid-Study Changes

In our experience, our MedTech customers typically undergo at least one mid-study change during the course of their trials. A Tufts study done in 2021 found that the average time to resume a study after a mid-study change was 35-40 days. That’s almost two months where your study is offline! During Those two months costs aggregate, staff are left to wait, and you lose eligible subjects.

Medrio has a proven approach to mid-study changes. For every study, we build three different environments: a development, a test, and a live environment. The mid-study change is first built in the development environment, then undergoes testing in the test environment. Once the change is functioning properly, it’s pushed to the live production environment. Because we build and test in separate environments, there’s no production downtime during a mid-study change.

As a result of our intuitive drag-and-drop interface, mid-study changes can be made very quickly, typically within hours or days. Our average mid-study change takes just 7 hours to implement; a significant improvement from the industry-standard 35 to 40 days. This turnaround time helps preserve study continuity, save costs, and of course, get your device to market faster.


If you apply this five pronged approach, reducing or removing paper, using ‘right-sized’ technology, reusing your technology, applying integrated solutions, and preparing for mid-study changes, you will reduce your cost and get your devices to market faster.

Request a demo to see our products in action.